IBISWorld Platform
Answer any industry question in minutes with our entire database at your fingertips.
PolyNovo is a Public Company that generates the majority of its income from the Medical and Surgical Equipment Manufacturing industry. In 2025 the company generated total revenue of $129,186,000 including sales and other revenue. In 2025 PolyNovo had 301 employees including employees from all subsidiaries under the company's control. The Chief Executive of PolyNovo is Mr Bruce Peatey whose official title is Chief Executive Officer. The Chairman of PolyNovo is Mr Leon Hoare whose official title is Non-Executive Chairman. PolyNovo Limited develops a number of medical products utilising the patented bioabsorbable polymer technology NovoSorb. The product comes in a variety of formats including: Films Foam Coatings / Sprays Fibres Plastic Structures Biological Carrier
Answer any industry question in minutes with our entire database at your fingertips.
Feed trusted, human-driven industry intelligence straight into your platform.
Streamline your workflow with IBISWorld’s intelligence built into your toolkit.
IBISWorld's research coverage on the Polynovo Limited includes market sizing, forecasting, data and analysis. The most recent publication will be as current as of March 2026.
Polynovo Limited, trading as PolyNovo, operates under the ABN 96 083 866 862 and was incorporated on 12 August 1998. Polynovo Limited trades on the Australian Securities Exchange under the ticker code ASX:PNV. Polynovo Limited primarily operates in the Medical and Surgical Equipment Manufacturing industry in Australia.
The Key Personnel chapter outlines the principal leadership positions within Polynovo Limited, including the Chairman, Board members, Chief Executive Officer, and other key management personnel. It provides an overview of the company’s governance and executive structure, along with a breakdown of gender diversity across leadership roles, offering insight into the composition of the organisation’s senior team.
The Financials chapter presents Polynovo Limited’s historical financial performance, including detailed profit and loss statements outlining sales revenue, cost of sales, and profitability. It also incorporates balance sheet data, providing a breakdown of assets and liabilities, as well as additional financial metrics such as the number of shares on issue. Together, these disclosures offer a comprehensive view of the company’s financial position and performance over time.
The Growth & Ratios chapter provides historical data on key financial performance indicators, enabling an assessment of the company’s operational efficiency, profitability, and financial structure over time. Metrics covered include return on equity, return on assets, profit margins, revenue per employee, as well as gearing and leverage ratios, offering a comprehensive view of performance trends and capital management.
The Operating Segments chapter provides an overview of the revenue composition and asset allocation across the various industries in which Polynovo Limited operates. It offers insights into how the company’s financial performance is distributed among its core business segments, highlighting the relative contribution of each industry to total revenue.
The Competitor Benchmarking chapter includes a comparative assessment of Polynovo Limited’s key financial, growth, and valuation ratios against industry averages to evaluate its competitive position. It analyses valuation metrics such as price-to-earnings, price-to-book, enterprise value to EBITDA, and enterprise value to sales, alongside core financial indicators including liquidity ratios and profitability measures.
The Shareholders chapter provides a breakdown of the ownership structure of Polynovo Limited, identifying key shareholders and outlining their respective ownership interests. This section offers insight into the concentration of shareholdings, the presence of institutional or strategic investors, and the overall distribution of equity within the company.
The Subsidiaries chapter provides an overview of the companies and business entities that are wholly or partially owned by Polynovo Limited. It outlines the ownership structure of each subsidiary, offering insight into the broader corporate group and how these entities contribute to the company’s overall activities and performance.
The History chapter presents a overview of Polynovo Limited’s development, highlighting key milestones and significant corporate events since its incorporation. It includes the company’s incorporation date and outlines major strategic, operational, and structural developments, providing context for its evolution and current market position.
More than 6,000 businesses use IBISWorld to shape local and global economies
We were able to supplement our reports with IBISWorld’s information from both a qualitative and quantitative standpoint. All of our reporting now features some level of IBISWorld integration.
IBISWorld delivers the crisp business knowledge we need to drive our business. Whether it be serving up our major clients, winning new business or educating on industry issues, IBISWorld brings real value.
IBISWorld has revolutionised business information — which has proved commercially invaluable to exporters, investors and public policy professionals in Australia and overseas.
When you’re able to speak to clients and be knowledgeable about what they do and the state that they operate in, they’re going to trust you a lot more.
PolyNovo Limited develops a number of medical products utilising the patented bioabsorbable polymer technology NovoSorb. The product comes in a variety of formats including: Films Foam Coatings / Sprays Fibres Plastic Structures Biological Carrier
Polynovo Limited, trading as PolyNovo, is a Public Company that generates the majority of its income from the Medical and Surgical Equipment Manufacturing industry in Australia.
Murray Cod Australia Limited company is based at 320 Lorimer Street, Port melbourne, Victoria, Australia.
The Chief Executive Officer of Polynovo Limited is Leon Hoare and the Chief Executive Officer is Bruce Peatey.
In 2025, Polynovo Limited generated total revenue of approximately $129.2 million.